Effect of dehydroepiandrosterone (DHEA) supplementation on fatty acid and hormone levels in patients with X-linked adrenoleukodystrophy
Assies, J.; Haverkort, E.B.; Lieverse, R.; Vreken, P.
Advances in Experimental Medicine and Biology 544: 243-244
2003
ISSN/ISBN: 0065-2598 PMID: 14713236 Document Number: 562012
Document emailed within 1 workday
Related Documents
Kawamura, N.; Moser, H.W.; Kishimoto, Y.; Schaumburg, H.; Suzuki, K.; Murphy, J. 1978: Excess C-26 fatty acid in cultured skin fibroblasts from adrenoleukodystrophy and adrenomyeloneuropathy patients Transactions of the American Neurological Association 103: 113-115Borman, E.; Check, J.H.; Mitchell-Williams, J.; Cohen, R. 2012: No evidence to support the concept that low serum dehydroepiandrosterone (DHEA) sulfate (s) levels are associated with less oocyte production or lower pregnancy rates Clinical and Experimental Obstetrics and Gynecology 39(4): 429-431
Armada, E.; Pérez Melón, C.; Otero, A.; Gayoso, P.; Rodríguez, M.; Esteban Morcillo, J. 2001: Effect of folic acid supplementation on total homocysteine levels in hemodialysis patients Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 21(2): 167-173
Hansen, H.S.; Jensen, B. 1986: Urinary excretion of arginine-vasopressin and prostaglandin E2 in essential fatty acid-deficient rats after oral supplementation with unsaturated fatty acid esters Journal of Nutrition 116(2): 198-203
Schutgens, R.B.; Bouman, I.W.; Nijenhuis, A.A.; Wanders, R.J.; Frumau, M.E. 1993: Profiles of very-long-chain fatty acids in plasma, fibroblasts, and blood cells in Zellweger syndrome, X-linked adrenoleukodystrophy, and rhizomelic chondrodysplasia punctata Clinical Chemistry 39(8): 1632-1637
Sonka, J.; Krizek, V.; Gregorova, I.; Vrbova, H.; Pikalova, J.; Josfko, M.; Staś, J. 1973: Gout and dehydroepiandrosterone. I. DHEA excretion Endokrynologia Polska 24(3): 193-199
Kjeldsen-Kragh, J.; Lund, J.A.; Riise, T.; Finnanger, B.; Haaland, K.; Finstad, R.; Mikkelsen, K.; Førre, O. 1992: Dietary omega-3 fatty acid supplementation and naproxen treatment in patients with rheumatoid arthritis Journal of Rheumatology 19(10): 1531-1536
Memon, R.A.; Feingold, K.R.; Moser, A.H.; Fuller, J.; Grunfeld, C. 1998: Regulation of fatty acid transport protein and fatty acid translocase mRNA levels by endotoxin and cytokines American Journal of Physiology 274(2): E210-E217
Heijboer, A.C.; Zimmerman, Y.; de Boer, T.; Coelingh Bennink, H.; Blankenstein, M.A. 2014: Peculiar observations in measuring testosterone in women treated with oral contraceptives supplemented with dehydroepiandrosterone (DHEA) Clinica Chimica Acta; International Journal of Clinical Chemistry 430: 92-95
Porter, J.R.; Abadie, J.M.; Wright, B.E.; Browne, E.S.; Svec, F. 1995: The effect of discontinuing dehydroepiandrosterone supplementation on Zucker rat food intake and hypothalamic neurotransmitters International Journal of Obesity and Related Metabolic Disorders: Journal of the International Association for the Study of Obesity 19(7): 480-488
Zehaluk, C.M.; Walker, B.L. 1973: Effect of pyridoxine on red cell fatty acid composition in mature rats fed an essential fatty acid-deficient diet Journal of Nutrition 103(11): 1548-1553
Alling, C.; Bruce, A.; Karlsson, I.; Sapia, O.; Svennerholm, L. 1972: Effect of maternal essential fatty acid supply on fatty acid composition of brain, liver, muscle and serum in 21-day-old rats Journal of Nutrition 102(6): 773-782
Aust, L.; Bruckner, J.; Levachev, M.M.; Noak, R.; Pokrovskiĭ, A.A. 1978: Effect of fatty acid triglycerides on lipogenesis and the makeup of plasma, fatty tissue and erythocyte membrane fatty acids in rats Voprosy Pitaniia 4: 18-23
Manku, M.S.; Morse-Fisher, N.; Horrobin, D.F. 1988: Changes in human plasma essential fatty acid levels as a result of administration of linoleic acid and gamma-linolenic acid European Journal of Clinical Nutrition 42(1): 55-60
Azzam, M.; Attalla, S. 2019: Serum Folate Levels in Patients with Chronic Hemolytic Anemia on Regular Folic Acid Supplementation Before and After Dose Modification Indian Pediatrics 56(10): 845-848
Zur Mühlen A von; Hesch, R.D.; Emrich, D.; Creutzfeldt, W. 1970: Effect of synthetic "thyreotropin releasing factor" on the plasma levels of thyreotropic hormone and growth hormone in healthy subjects, in patients with hyperthyreosis and primary hypothyreosis Deutsche Medizinische Wochenschrift 95(52): 2623-2624
Sucić, M.; Katica, D.; Kovacević, V. 1998: Effect of dietary fish supplementation on lipoprotein levels in patients with hyperlipoproteinemia Collegium Antropologicum 22(1): 77-83
Elliott, R.B. 1976: A therapeutic trial of fatty acid supplementation in cystic fibrosis Pediatrics 57(4): 474-479
Brown, F.R.; Van Duyn, M.A.; Moser, A.B.; Schulman, J.D.; Rizzo, W.B.; Snyder, R.D.; Murphy, J.V.; Kamoshita, S.; Migeon, C.J.; Moser, H.W. 1982: Adrenoleukodystrophy: effects of dietary restriction of very long chain fatty acids and of administration of carnitine and clofibrate on clinical status and plasma fatty acids Johns Hopkins Medical Journal 151(4): 164-172
Cappelli, P.; Di Liberato, L.; Stuard, S.; Ballone, E.; Albertazzi, A. 1997: N-3 polyunsaturated fatty acid supplementation in chronic progressive renal disease Journal of Nephrology 10(3): 157-162